Month: August 2020

Company AnnouncementDARZALEX® (daratumumab) approved by U.S. FDA in combination with carfilzomib and dexamethasone for the treatment of adult patients with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy Approval based on the Phase 3 CANDOR studyApproval marks eighth U.S. FDA approval for DARZALEXCopenhagen, Denmark; August 20, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that the U.S. Food and Drug Administration (U.S. FDA) has approved the use of DARZALEX® (daratumumab) in combination with carfilzomib and dexamethasone (DKd) for the treatment of adult patients with relapsed/refractory multiple myeloma who have received one to three previous lines of therapy.  A supplemental Biologics License Application (sBLA) for this indication was submitted by Genmab’s licensing partner, Janssen Biotech,...

TORONTO and HOUSTON, Aug. 20, 2020 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (Nasdaq: MDNA) (TSX: MDNA), a clinical stage immuno-oncology company, today announced that the Company’s common shares have been approved for listing on The Nasdaq Capital Market (“Nasdaq”). Trading is expected to begin on Monday, August 24, 2020, under the symbol “MDNA” on the Nasdaq.  The Corporation will retain its listing on the Toronto Stock Exchange under the symbol “MDNA” and the Company’s common shares will continue to trade on the OTCQB under the symbol “MDNAF” until trading on the Nasdaq commences.“The listing of our stock on the Nasdaq represents a significant milestone in our growth as a publicly-traded company,” said Fahar Merchant, PhD, President and CEO...

Not for distribution to U.S. news wire services or for dissemination in the United StatesTORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Avante Logixx Inc. (TSX.V: XX) (OTC: ALXXF) (“Avante” or the “Company”) is pleased to announce that it will release its financial results for the quarter ended June 30, 2020 after market close on Wednesday, August 26, 2020 and a news release will be disseminated at that time with an earnings call at 8:30 AM EST on Thursday, August 27, 2020.CONFERENCE CALLAvante will be hosting a conference call to discuss the above financial results on Thursday, August 27, 2020, at 8:30 AM EST.This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities described herein in any jurisdiction in which such offer, solicitation or sale would be...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — Summit Industrial Income REIT (“Summit” or the “REIT”) (TSX: SMU.UN) announced today that it has entered into an agreement with a syndicate of underwriters led by BMO Capital Markets (collectively, the “Underwriters“) to sell, on a bought deal basis, 12,500,000 Units at a price of $12.00 per Unit for gross proceeds to Summit of approximately $150 million (the “Offering“). In addition, Summit has granted the Underwriters an over-allotment option to purchase up to an additional 1,875,000 Units on the same terms and conditions, exercisable at any time, in whole or in part, up to 30 days after the closing of the Offering. The Offering is expected to close on or about August...

YORKTOWN HEIGHTS, N.Y., Aug. 20, 2020 (GLOBE NEWSWIRE) — PCSB Financial Corporation (the “Company”) (NASDAQ: “PCSB”), parent of PCSB Bank, announced today that it has authorized a program to repurchase up to 844,907 shares, or 5%, of its outstanding common stock.  The timing and amount of any repurchases will depend on various factors, including but not limited to, market conditions, stock price, and alternative uses of capital.  Repurchases may be transacted in the open-market or in negotiated private transactions and may be conducted pursuant to a trading plan adopted in accordance with Securities and Exchange Commission Rule 10b5-1.About PCSB Financial Corporation and PCSB BankPCSB Financial Corporation is the bank holding company for PCSB Bank, a New York-chartered commercial bank.  PCSB Bank has served the banking needs of...

AUSTIN, Texas, Aug. 20, 2020 (GLOBE NEWSWIRE) — BigCommerce Holdings, Inc. (“BigCommerce”) (Nasdaq: BIGC), a leading software-as-a-service (SaaS) ecommerce platform that empowers merchants of all sizes to build, innovate and grow their businesses online, today announced that it will report its financial results for the second quarter ended June 30, 2020 after market close on Wednesday, September 9, 2020.The financial results and business highlights will be discussed on a conference call and webcast scheduled at 4:00 p.m. CT (5:00 p.m. ET) on Wednesday, September 9, 2020. The conference call can be accessed by dialing (833) 519-1347 from the United States and Canada or (914) 800-3909 internationally with conference ID 5080457. The live webcast of the conference call can be accessed from BigCommerce’s investor relations website at...

TORONTO, Aug. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — R-Three Technologies, Inc. (OTC: RRRT), after several years of inactivity, is pleased to announce that the company is taking measures to deliver increased value for shareholders, via an improved capital structure and the launch of several new, strategic initiatives.As a first initiative, R-Three Technologies, Inc. (OTC: RRRT) has cancelled $564,000 of debt, as per company quarterly filing with OTC. Additionally, R-Three Technologies, Inc. will soon be announcing a new restructuring of its equity.R-Three Technologies, Inc. (OTC: RRRT) has been working diligently on several other new measures that aim to drive shareholder value. These include new mergers and acquisitions strategy and the hiring of a new senior management team to execute these plans.“We’re excited about...

Hamilton, Bermuda, August 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today announced that it has regained compliance with the Nasdaq listing requirements. On August 20, 2020, the Company received a letter from Nasdaq stating that because the Company’s shares had a closing bid price at or above $1.00 per share for a minimum of ten (10) consecutive business days, the Company’s stock had regained compliance with the Minimum Bid Price Requirement for continued listing on Nasdaq, and that the matter is now closed.About Auris MedicalAuris Medical is a biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in neurotology and...

WINNIPEG, Manitoba, Aug. 20, 2020 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its second quarter 2020 financial results after market close on Thursday, August 27, 2020.Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period.Second Quarter 2020 Results Conference Call Details:The call will also be broadcast live and archived on the Company’s website at www.kanebiotech.com under “News/Events” in the Investors section.About Kane Biotech Inc.Kane Biotech is a biotechnology company engaged in the research,...

SAN MATEO, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) — Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) (the “Company” or “PLUS”), a cannabis branded products company in the U.S., today released its unaudited financial and operational results for the three and six months ended June 30, 2020, expressed in U.S. dollars. These filings are available for review on the Company’s SEDAR profile at www.sedar.com and on the Canadian Securities Exchange (the “CSE”) website at www.thecse.com.Q2 2020 Financial HighlightsRevenues: Net revenues reached $4.3M in Q2 2020, representing 21% year-over-year growth as compared to Q2 2019 net revenues of $3.6M. The Company continues to see revenue growth driven by its core operations in the California adult-use market, with contributions from new brand launches, the Nevada adult-use market, and its national...